Tuesday, November 13, 2018
Tags Ophthalmology and Vision

Tag: Ophthalmology and Vision

EyeBuyDirect Launches New Line of RFLKT Glasses – Premium Winter Eyewear

AUSTIN, Texas, Nov. 9, 2018 (SEND2PRESS NEWSWIRE) -- EyeBuyDirect today announced a new line of RFLKT glasses designed with the winter months in the forefront. New styles released include Planete, Illusion, Resonance, Luminous and Era, and will be available starting November 12. The five new frames in EyeBuyDirect's premium line reflect the best winter has to offer when it comes to colors - clear blue, pink golden and brown striped.
Lucyd Loud

The smart future in your eyes is now: Lucyd Loud, the latest tech in smart prescription eye glasses

MIAMI, Fla. /Florida Newswire/ -- Answer and control phone calls, text via voice, listen to music, receive notifications and access WhatsApp without the need to take your smartphone out of your pocket, and still be able to hear the world around you. Say hello to Lucyd Loud.

EyeBuyDirect Launches its New ‘Catch of the Day’ Summer Collection

AUSTIN, Texas, July 9, 2018 (SEND2PRESS NEWSWIRE) -- At the beach or by the pool, EyeBuyDirect's new Catch of the Day summer collection, released today, aims to highlight an individual's personal style. As the fastest-growing online prescription eyewear retailer, the collection marks the beginning of EyeBuyDirect's #ItsHowYouFrameIt campaign, which focuses on bright colors, limitless expression and positivity.

EyeBuyDirect Announces 2018 ‘Buy 1 Give 1’ Initiative, Will Donate a Pair of Glasses with Every Order

AUSTIN, Texas, May 9, 2018 (SEND2PRESS NEWSWIRE) -- EyeBuyDirect, the online prescription eyewear retailer, announced today a "Buy 1 Give 1" Program that donates a pair of prescription glasses to someone in need worldwide for every transaction made through the online retailer. As a part of the Essilor Group, this new initiative directly supports Vision for Life, a social impact fund giving access to vision care to the most underserved communities worldwide.

Alejandro Arboleda Named 2018 Koch Kellan Scholar

PORTLAND, Ore., April 13, 2018 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.

EyeBuyDirect Launches Winter Whims 2017 Fall-Winter Collection

AUSTIN, Texas, Nov. 17, 2017 (SEND2PRESS NEWSWIRE) -- The fastest growing online eyewear retailer, EyeBuyDirect, has launched its new collection, Winter Whims. The collection includes 21 frames that embody the colors, textures and feeling of winter. The new Winter Whims collection is available online now. It features chocolate-brown and cinnamon-red frames that invoke the smell and tastes of the holiday season.

Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship

PORTLAND, Ore., Oct. 2, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.

Xinxin Zhang Named 2017 Koch Kellan Scholar

PORTLAND, Ore., April 12, 2017 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

Ruling Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formula

PORTLAND, Ore., Nov. 21, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc. (Paragon), announces a monumental ruling handed down by the United States Patent and Trademark Office affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

Paragon BioTeck Announces Call for 2017 Koch Kellan Medical Scholarship Applicants

PORTLAND, Ore., Sept. 1, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.

Hasenin Al-khersan Named 2016 Koch Kellan Scholar

PORTLAND, Ore., April 18, 2016 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

PORTLAND, Ore., Oct. 15, 2014 (SEND2PRESS NEWSWIRE) -- Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic pharmaceuticals, devices and therapies, will be exhibiting at the American Academy of Ophthalmology (Booth #4550) in Chicago, Ill., on October 18 - 21.

Novel Protein May Hold Promise for Enhancing Artificial Tear Formulations

PLYMOUTH, Minn., Oct. 14, 2014 (SEND2PRESS NEWSWIRE) -- SilkTears, LLC, a privately held, research-based and product-driven biotechnology company, announced today that advances in protein-based excipient technology may allow for the development of artificial tear products that will more closely represent certain characteristics of the natural makeup of the tear film, and may help the significant population of patients suffering from dry eye syndrome.

FEATURED NEWS

NATIONAL NEWS